They can contribute to better skin health, enhancing complexion and brightness
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the treatment of obesity and type 2 diabetes mellitus (T2DM) by mimicking endogenous GLP-1 activity, increasing glucose-dependent insulin secretion and suppressing glucagon release
HUBERMAN: So, Some peptides have been approved for one use, but they can be prescribed also for off-label use
Langman CB, Delos Santos RB, Ghossein C, Atherton AM, Levtchenko EN, Servais A (2024) Fertility management in cystinosis: a clinical perspective
Patients with a history of diabetic retinopathy should have baseline ophthalmology evaluation, as rapid glucose lowering may temporarily worsen vision